文献速递血栓与止血

急性肺栓塞患者住院与门诊管理的净临床获益比较

Net clinical benefit of hospitalization versus outpatient management of patients with acute pulmonary embolism.
PubMed 文献 · J Thromb Haemost · 2017-02-25

该回顾性倾向评分匹配队列研究纳入1081例血流动力学稳定的急性肺栓塞患者,比较住院与门诊管理的净临床获益。14天不良事件率住院组13.0% vs 门诊组3.3%(校正OR 5.07,95%CI 1.68-15.28),3个月为21.7% vs 6.9%(OR 4.90,95%CI 2.62-9.17)。作者认为门诊治疗似乎与较低不良事件率相关,若被证实可考虑作为一线管理。

要点

  • 血流动力学稳定的急性肺栓塞患者中,住院组14天不良事件率13.0%,门诊组3.3%(校正OR 5.07)。
  • 3个月不良事件率住院组21.7%,门诊组6.9%(OR 4.90,95%CI 2.62-9.17)。
  • 高危亚组(肺栓塞严重指数III-V级,n=597)14天不良事件率住院组16.5% vs 门诊组4.5%(OR 4.16)。

核心结论

  • 血流动力学稳定的肺栓塞患者门诊治疗似乎与较低不良事件率相关,若被证实,在无需特定住院治疗且能提供适当门诊照护的患者中可考虑作为一线管理,不论初始风险分层如何。

研究设计与样本

  • 回顾性队列倾向评分分析(radius matching with replacement),将血流动力学稳定的肺栓塞门诊或住院患者按28项患者特征和已知不良事件危险因素进行匹配。
  • 1127例符合条件患者中,1081例纳入匹配队列,其中住院治疗576例,门诊治疗505例。

主要发现

  • 14天不良事件率住院组为13.0%,门诊组为3.3%(校正OR 5.07;95%CI 1.68-15.28)。
  • 3个月不良事件率住院组为21.7%,门诊组为6.9%(OR 4.90;95%CI 2.62-9.17)。
  • 高危亚组(肺栓塞严重指数III-V级;n=597)14天不良事件率住院组为16.5%,门诊组为4.5%(OR 4.16;95%CI 1.2-14.35)。

临床怎么用

  • 作者认为,血流动力学稳定的肺栓塞患者门诊治疗似乎与较低不良事件率相关,若被证实,在无需特定住院治疗且能提供适当门诊照护的患者中可考虑作为一线管理,不论初始风险分层如何。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

UNLABELLED: Essentials Clinical benefit of hospitalization vs. outpatient treatment in pulmonary embolism (PE) is unknown. We performed a propensity matched cohort study of hemodynamically stable PE patients. Regardless of the risk assessment, hospitalized patients had the highest rate of adverse event. If confirmed, ambulatory care of normotensive PE patients may be preferred whenever possible. SUMMARY: Background The decision to hospitalize or not patients with acute pulmonary embolism (PE) is controversial. Despite the advantages of close monitoring, hospitalization by itself may lead to in-hospital complications and potentially worsen the prognosis of PE patients. Objectives To determine the net clinical benefit of hospitalization vs. outpatient management of normotensive patients with acute pulmonary embolism (PE). Methods Retrospective cohort propensity score analysis (radius marching with replacement). Hemodynamically stable PE patients treated as outpatients or inpatients were matched to balance out differences for 28 patient characteristics and known risk factors for adverse events. The primary outcome was the rate of adverse events at 14 days, including recurrent venous thromboembolism, major bleeding or death. Results Among 1127 eligible patients, 1081 were included in the matched cohort, 576 treated as inpatients and 505 as outpatients. The 14-day rate of adverse events was 13.0% for inpatients and 3.3% for outpatients (adjusted OR, 5.07; 95% CI, 1.68-15.28). The 3-month rate was 21.7% for inpatients and 6.9% for outpatients (OR, 4.90; 95% CI, 2.62-9.17). In the high-risk subgroup (Pulmonary Embolism Severity Index class III-V; n = 597), the 14-day rate of adverse events was 16.5% for hospitalized patients vs. 4.5% for outpatients (OR, 4.16; 95% CI, 1.2-14.35). Conclusion Outpatient treatment of hemodynamically stable PE patients seems to be associated with a lower rate of adverse events than hospitalization and, if confirmed, may be considered as first-line management in patients not requiring specific in-hospital care, regardless of their initial risk stratification, if proper outpatient care can be provided.

来源:J Thromb Haemost,查看原文。版权归原作者所有。

引用

  1. Roy PM, Corsi DJ, Carrier M, et al. Net clinical benefit of hospitalization versus outpatient management of patients with acute pulmonary embolism. J Thromb Haemost. 2017. PMID: 28106343. doi:10.1111/jth.13629

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。